Brainsway (BWAY) EBT Margin (2018 - 2026)
Brainsway (BWAY) posted quarterly EBT Margin of 15.52% for Q1 2026, up 456.0% year-on-year from 2.79% in Q1 2025, and down 23.05% on a QoQ basis from 20.17% in Q4 2025.
Brainsway (BWAY) EBT Margin (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported EBT Margin for 9 consecutive years, with 15.52% the latest figure, recorded in Q1 2026.
- Quarterly EBT Margin rose 456.0% year-over-year to 15.52% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.45% (up 623.0% YoY) and the FY2025 annual result came in at 14.76%, up 633.0% from the prior year.
- EBT Margin declined to 15.52% in Q1 2026 per BWAY's latest filing, from 20.17% in the prior quarter.
- Over the last five years, EBT Margin for BWAY reached as high as 20.17% in Q4 2025 and fell as low as 96.15% in Q3 2022.
- A 5-year average of 9.38% and a median of 3.11% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin slumped 7639 bps — and 2023, when it jumped 9409 bps.
- Year by year, EBT Margin stood at 65.01% in 2022, then soared by 99 bps to 0.41% in 2023, then soared by 3812 bps to 15.21% in 2024, then jumped by 33 bps to 20.17% in 2025, then dropped by 23 bps to 15.52% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 15.52%, 20.17%, and 13.38% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 15.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.52% |
| Dec 31, 2025 | 20.17% |
| Sep 30, 2025 | 13.38% |
| Jun 30, 2025 | 16.60% |
| Mar 31, 2025 | 10.96% |
| Dec 31, 2024 | 15.21% |
| Sep 30, 2024 | 7.02% |
| Jun 30, 2024 | 7.03% |
| Mar 31, 2024 | 3.11% |
| Dec 31, 2023 | -0.41% |
| Sep 30, 2023 | -2.06% |
| Jun 30, 2023 | -18.88% |
| Mar 31, 2023 | -34.11% |
| Dec 31, 2022 | -65.01% |
| Sep 30, 2022 | -96.15% |
| Jun 30, 2022 | -29.19% |
| Mar 31, 2022 | -22.66% |
| Dec 31, 2021 | -21.62% |
| Sep 30, 2021 | -19.76% |
| Jun 30, 2021 | -25.44% |